ARCHIVES

NCI To Offer Compromise On Including “Chop-Like Elements” In CCOP, Agrees Consortia “Appropriate”

This article is from The Cancer Letter archive.

Vol. 08 No. 20 | May 14, 1982

Download PDF Visit The Full Archive

Related Articles

Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease

October 31, 2014

CCIRC Considers Programs Involved with Including Multimodality Studies

October 10, 1975

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

February 17, 2006

Firm Reports Limited Market For Self-Test Detection Methods

July 29, 1983

NCI Proposes Inviting Academic Labs To Submit New Therapies For Development

January 23, 1998

DCT Board Sends Letter Opposing Bill Requiring Research On RU 486

November 13, 1992